Corium Innovations, Inc.
4 clinical trials · Sponsor
◉ Watch Corium Innovations, Inc.
| Record | Firm | Date |
|---|---|---|
| A Study to Assess the Skin Irritation and Sensitization of Selegiline TDS in Healthy Subjects (NCT07452692) | Corium Innovations, Inc. | 2026-07-01 |
| A Study to Assess the Bioavailability and Adhesion of Selegiline TDS in Healthy Subjects (NCT07571824) | Corium Innovations, Inc. | 2026-03-23 |
| Determine PK Profiles of Ozanimod and Its' Major Metabolites in Healthy Subjects (NCT06528665) | Corium Innovations, Inc. | 2025-02-10 |
| Determine the Bioavailability of Selegiline TDS 6mg/24 Hours vs EMSAM in Healthy Subjects (NCT06607744) | Corium Innovations, Inc. | 2025-02-10 |
Track Corium Innovations, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.